COVID‐Q: Validation of the first COVID‐19 questionnaire based on patient‐rated symptom gravity
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.07.24.21261065: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: This study was approved by the Ethical Committees of the Academic Hospital of Treviso (Italy) and the Hospital of Belluno (Italy), and it was conducted in accordance with the principles of the Helsinki Declaration.
Consent: All participants gave their consent to be enrolled in this investigation and to the treatment of their personal data for scientific purposes.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results …SciScore for 10.1101/2021.07.24.21261065: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: This study was approved by the Ethical Committees of the Academic Hospital of Treviso (Italy) and the Hospital of Belluno (Italy), and it was conducted in accordance with the principles of the Helsinki Declaration.
Consent: All participants gave their consent to be enrolled in this investigation and to the treatment of their personal data for scientific purposes.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Another limitation of the present study is the number of patients. Even if it’s statistically significant, a wider application of the COVID-Q to a larger number of patients may allow to obtain even more precise results and, possibly, to adjust the model we suggested with the present study. It must be observed, also, that being SARS-CoV-2 an RNA virus, it can mutate into diverse variants which may give diverse presentations of COVID-19. Therefore, possible score differences may be encountered by using the questionnaire. At last, the present study has been conducted in a single geographical area, so its application in different areas of other Countries may be useful in order to observe any possible score differences. In conclusion, in this study we developed and proposed a novel questionnaire to assess and scale the COVID-19-associated symptoms. Its application to COVID-19 patients could improve the reliability in collecting clinical data and assessing the severity of symptoms, while its extension to subjects who have not received a COVID-19 diagnosis yet might help to identify those at higher risk of being affected and, therefore, needing a microbiological test.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
